Co-Diagnostics, Inc. Accounts Receivable, Credit Loss Expense (Reversal)
Co-Diagnostics, Inc. (CODX) reported Accounts Receivable, Credit Loss Expense (Reversal) of -$22.38 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ProvisionForDoubtfulAccounts · last filed 2025-11-13
- Co-Diagnostics, Inc. accounts receivable, credit loss expense (reversal) for the quarter ending 2025-09-30 was -$9.13K, a 118.55% decline year-over-year.
- Co-Diagnostics, Inc. accounts receivable, credit loss expense (reversal) for the quarter ending 2025-06-30 was -$17.39K.
- Co-Diagnostics, Inc. accounts receivable, credit loss expense (reversal) for the quarter ending 2025-03-31 was $4.14K.
- Co-Diagnostics, Inc. accounts receivable, credit loss expense (reversal) for the quarter ending 2024-12-31 was -$23.30K, a 121.25% decline year-over-year.
- Co-Diagnostics, Inc. accounts receivable, credit loss expense (reversal) for fiscal 2024 was -$15.04K, a 102.45% decline from fiscal 2023.
- Co-Diagnostics, Inc. accounts receivable, credit loss expense (reversal) for fiscal 2023 was $612.81K, a 75.10% decline from fiscal 2022.
- Co-Diagnostics, Inc. accounts receivable, credit loss expense (reversal) for fiscal 2022 was $2.46M, a 3432.31% increase from fiscal 2021.
- Co-Diagnostics, Inc. accounts receivable, credit loss expense (reversal) for fiscal 2021 was $69.67K, a 92.70% decline from fiscal 2020.
| Period end | Accounts Receivable, Credit Loss Expense (Reversal) 3 month | Accounts Receivable, Credit Loss Expense (Reversal) 3 month as first filed | Accounts Receivable, Credit Loss Expense (Reversal) 6 month | Accounts Receivable, Credit Loss Expense (Reversal) 6 month as first filed | Accounts Receivable, Credit Loss Expense (Reversal) 9 month | Accounts Receivable, Credit Loss Expense (Reversal) 9 month as first filed | Accounts Receivable, Credit Loss Expense (Reversal) 12 month | Accounts Receivable, Credit Loss Expense (Reversal) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | -$9.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | -$26.52K derived: sum of 2 quarters · filed 2025-11-13 | -$22.38K 10-Q · filed 2025-11-13 | -$45.67K derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2025-06-30 | -$17.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$13.25K 10-Q · filed 2025-08-14 | -$36.55K derived: sum of 3 quarters · filed 2025-08-14 | $12.66K derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2025-03-31 | $4.14K 10-Q · filed 2025-05-08 | -$19.15K derived: sum of 2 quarters · filed 2025-05-08 | $30.05K derived: sum of 3 quarters · filed 2025-11-13 | $3.77K derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-12-31 | -$23.30K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $25.91K derived: sum of 2 quarters · filed 2025-11-13 | -$377.00 derived: sum of 3 quarters · filed 2025-11-13 | -$15.04K 10-K · filed 2025-03-27 | ||||
| 2024-09-30 | $49.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $22.92K derived: sum of 2 quarters · filed 2025-11-13 | $8.26K 10-Q · filed 2025-11-13 | $117.89K derived: sum of 4 quarters · filed 2025-11-13 | ||||
| 2024-06-30 | -$26.29K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$40.94K 10-Q · filed 2025-08-14 | $68.68K derived: sum of 3 quarters · filed 2025-08-14 | $80.70K derived: sum of 4 quarters · filed 2025-08-14 | ||||
| 2024-03-31 | -$14.66K 10-Q · filed 2025-05-08 | $94.97K derived: sum of 2 quarters · filed 2025-05-08 | $106.99K derived: sum of 3 quarters · filed 2025-05-08 | $712.15K derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | $109.63K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $121.65K derived: sum of 2 quarters · filed 2025-03-27 | $726.81K derived: sum of 3 quarters · filed 2025-03-27 | $612.81K 10-K · filed 2025-03-27 | ||||
| 2023-09-30 | $12.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $617.18K derived: sum of 2 quarters · filed 2024-11-07 | $503.18K 10-Q · filed 2024-11-07 | $326.65K 10-Q · filed 2023-11-09 | $2.63M derived: sum of 4 quarters · filed 2024-11-07 | |||
| 2023-06-30 | $605.16K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $491.16K 10-Q · filed 2024-08-08 | $314.63K 10-Q · filed 2023-08-10 | $2.61M derived: sum of 3 quarters · filed 2024-08-08 | $2.94M derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | -$114.00K 10-Q · filed 2024-05-09 | -$114.13K 10-Q · filed 2023-05-11 | $2.01M derived: sum of 2 quarters · filed 2024-05-09 | $2.34M derived: sum of 3 quarters · filed 2024-05-09 | $2.30M derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | $2.12M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $2.45M derived: sum of 2 quarters · filed 2024-03-14 | $2.41M derived: sum of 3 quarters · filed 2024-03-14 | $2.46M 10-K · filed 2024-03-14 | $2.43M 10-K · filed 2023-03-16 | |||
| 2022-09-30 | $326.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $290.19K derived: sum of 2 quarters · filed 2023-11-09 | $338.06K 10-Q · filed 2023-11-09 | $251.72K derived: sum of 4 quarters · filed 2023-11-09 | ||||
| 2022-06-30 | -$36.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $11.40K 10-Q · filed 2023-08-10 | -$74.94K derived: sum of 3 quarters · filed 2023-08-10 | -$66.70K derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $47.86K 10-Q · filed 2023-05-11 | -$38.48K derived: sum of 2 quarters · filed 2023-05-11 | -$30.24K derived: sum of 3 quarters · filed 2023-05-11 | $37.83K derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -$86.34K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$78.10K derived: sum of 2 quarters · filed 2023-03-16 | -$10.03K derived: sum of 3 quarters · filed 2023-03-16 | $69.67K 10-K · filed 2023-03-16 | ||||
| 2021-09-30 | $8.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $76.31K derived: sum of 2 quarters · filed 2022-11-10 | $156.01K 10-Q · filed 2022-11-10 | |||||
| 2021-06-30 | $68.08K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $147.78K 10-Q · filed 2022-08-11 | ||||||
| 2021-03-31 | $79.70K 10-Q · filed 2022-05-12 | |||||||
| 2020-12-31 | $954.80K 10-K · filed 2022-03-24 | |||||||
| 2020-06-30 | $493.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $524.39K 10-Q · filed 2021-08-12 | ||||||
| 2020-03-31 | $31.00K 10-Q · filed 2021-05-13 | |||||||
| 2019-12-31 | $11.00K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |